Phototherapy is the fastest and most effective way to reduce bilirubin in a newborn. It works within hours, converting bilirubin in the skin into a water-soluble form the baby can excrete without the liver needing to process it. For most newborns with jaundice, a combination of phototherapy and frequent feeding is enough to bring levels down safely. In severe cases, additional hospital procedures can lower bilirubin even faster.
How Phototherapy Works
Phototherapy uses blue light in the 400 to 520 nanometer range to change the structure of bilirubin molecules sitting in your baby’s skin. When bilirubin absorbs this light, it undergoes two chemical changes: photoisomerization, which reshapes the molecule so it dissolves in water, and photo-oxidation, which breaks it into smaller fragments. Both forms can then be excreted through urine and stool without needing to pass through the liver first. This is why phototherapy can produce visible results so quickly, often lowering bilirubin by 1 to 2 mg/dL within four to six hours of starting treatment.
Your baby will be placed under the light source wearing only a diaper and protective eye shields. The more skin that’s exposed, the more bilirubin gets converted. Treatment runs continuously, with breaks only for feeding. Most babies need phototherapy for one to two days, though the duration depends on how high bilirubin levels are and how quickly they drop.
Intensive vs. Standard Phototherapy
Not all phototherapy setups are equal. Standard phototherapy uses a single overhead light, while intensive phototherapy increases the light’s power or adds multiple light sources to cover more skin. The 2022 American Academy of Pediatrics guidelines base the decision between the two on your baby’s gestational age, age in hours, and whether neurotoxicity risk factors are present. These risk factors include being born before 38 weeks, having a hemolytic condition (where red blood cells break down faster than normal), infection, or low albumin levels in the blood.
When bilirubin is rising fast or levels are already high, intensive phototherapy is the standard recommendation. Some hospitals combine an overhead LED unit with a fiberoptic blanket placed underneath the baby, essentially surrounding the infant in therapeutic light. Studies comparing fiberoptic blankets alone to conventional overhead units found similar effectiveness, with both requiring roughly 42 to 44 hours of treatment in preterm infants. But using both together increases the total skin area receiving light and can speed the decline.
Why Frequent Feeding Matters
Bilirubin leaves the body primarily through stool. The more your baby eats, the more they stool, and the faster bilirubin clears. Research on breastfed newborns found that infants who nursed more than eight times per day in the first three days of life had significantly lower bilirubin levels than those who fed fewer than eight times. The difference was substantial: 6.5 mg/dL versus 9.3 mg/dL on average.
If your baby is under phototherapy, you’ll be encouraged to feed every two to three hours, aiming for 10 to 12 feedings per day. Breast milk and formula both work. The goal is to keep the gut moving. Some parents worry that breastfeeding causes jaundice, and while a specific pattern called breast milk jaundice does exist, the solution is almost never to stop breastfeeding. Instead, increasing feeding frequency addresses the issue directly by boosting bilirubin elimination.
A significant number of newborns admitted for high bilirubin are also somewhat dehydrated, often because breastfeeding hasn’t been fully established yet. Signs include excessive weight loss (more than 15% of birth weight), fever, or lethargy. When dehydration is present, the medical team may supplement with expressed breast milk, formula, or in more serious cases, intravenous fluids. Restoring hydration helps the body process and excrete bilirubin more efficiently.
When Bilirubin Levels Are Dangerously High
Exchange transfusion is the most aggressive treatment, reserved for cases where bilirubin rises to dangerous levels despite intensive phototherapy. During this procedure, small amounts of the baby’s blood are withdrawn and replaced with donor blood, physically removing bilirubin from the circulation. For premature babies, exchange transfusion thresholds vary by gestational age. A baby born before 28 weeks may need a transfusion at bilirubin levels of 11 to 14 mg/dL, while a baby born at 34 to 35 weeks has a higher threshold of 17 to 19 mg/dL. Full-term babies can generally tolerate higher levels before this step is considered.
For babies whose jaundice is caused by blood type incompatibility between mother and infant (isoimmune hemolytic disease), doctors sometimes use intravenous immunoglobulin (IVIG) to slow the destruction of red blood cells. The idea is that IVIG blocks the immune system from attacking the baby’s red blood cells, reducing the amount of bilirubin being produced in the first place. However, recent research has shown mixed results. A study in Frontiers in Pediatrics found that a single dose of IVIG did not reduce the need for exchange transfusion or shorten phototherapy time in babies with hemolytic disease from ABO blood type incompatibility. It remains an option in some cases, but it’s not a reliable standalone treatment.
Why Sunlight Is Not a Safe Substitute
The connection between sunlight and jaundice treatment goes back decades. The original discovery of phototherapy came from a nurse in England who noticed that sunlight bleached the skin of jaundiced premature infants. While sunlight does contain the right wavelengths to break down bilirubin, it also delivers high levels of ultraviolet and infrared radiation. For a newborn, this creates real risks of sunburn, overheating, and dehydration.
Researchers have developed filtered sunlight canopies that block UV and much of the infrared radiation, and these have been tested successfully in settings without access to electric phototherapy. But a filtered sunlight canopy is a medical device, not a sunny window. Placing your baby in direct or indirect sunlight at home does not deliver a controlled, therapeutic dose and carries risks that outweigh any benefit. If your baby’s bilirubin is high enough to need treatment, that treatment should be medical-grade phototherapy.
Warning Signs of Bilirubin Encephalopathy
The reason high bilirubin demands fast treatment is the risk of bilirubin crossing into the brain, a condition called bilirubin encephalopathy. It progresses through recognizable stages. Early on, you may notice your baby is extremely sleepy, has poor muscle tone, feeds poorly, or has lost the normal startle reflex. In the middle stage, the baby may develop a high-pitched cry, become irritable, and begin arching the back with the neck extended backward. Late-stage signs include seizures, no feeding at all, a shrill cry, and severe muscle rigidity.
These symptoms represent a medical emergency. The early signs, especially extreme sleepiness combined with poor feeding and visible jaundice, should prompt immediate evaluation. Bilirubin encephalopathy is preventable when caught and treated quickly, which is exactly why hospitals monitor bilirubin levels closely and act on them aggressively.
What You Can Do as a Parent
Your most powerful tool at home is feeding frequently and watching closely. Feed your baby at least 8 to 12 times per day in the first week. Track wet and dirty diapers to confirm your baby is getting enough milk. If your baby seems unusually sleepy, difficult to wake for feedings, or increasingly yellow (especially in the whites of the eyes, palms, or soles), get bilirubin checked promptly.
If your baby is already on phototherapy, keep them under the lights as much as possible. Every minute away from the light is a minute bilirubin isn’t being converted. Ask the care team about combining overhead and underneath light sources if levels aren’t dropping fast enough. Most importantly, understand that phototherapy is highly effective and most babies respond well within 24 to 48 hours. Jaundice is the most common reason newborns are readmitted to the hospital, but with prompt treatment, serious complications are rare.